These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 23936714)

  • 1. Lamotrigine augmentation of serotonin reuptake inhibitors in severe and long-term treatment-resistant obsessive-compulsive disorder.
    Arrojo-Romero M; Tajes Alonso M; de Leon J
    Case Rep Psychiatry; 2013; 2013():612459. PubMed ID: 23936714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brazilian Research Consortium on Obsessive-Compulsive Spectrum Disorders guidelines for the treatment of adult obsessive-compulsive disorder. Part I: pharmacological treatment.
    de Oliveira MVS; de Barros PMF; de Mathis MA; Boavista R; Chacon P; Echevarria MAN; Ferrão YA; Vattimo EFQ; Lopes AC; Torres AR; Diniz JB; Fontenelle LF; Rosário MCD; Shavitt RG; Miguel EC; da Silva RMF; Costa DLDC
    Braz J Psychiatry; 2023 May; 45(2):146-161. PubMed ID: 36749887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lamotrigine Augmentation Versus Placebo in Serotonin Reuptake Inhibitors-Resistant Obsessive-Compulsive Disorder: A Randomized Controlled Trial.
    Khalkhali M; Aram S; Zarrabi H; Kafie M; Heidarzadeh A
    Iran J Psychiatry; 2016 Apr; 11(2):104-14. PubMed ID: 27437007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful Early Lamotrigine and Aripiprazole Augmentation of Clomipramine in Severe Obsessive-compulsive Disorder.
    Seo EH; Kim SG; Lee JH; Yoon HJ
    Clin Psychopharmacol Neurosci; 2023 Aug; 21(3):604-608. PubMed ID: 37424428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of 5-hydroxytryptamine-3 (5-HT3) receptor antagonists in augmentation with selective serotonin reuptake inhibitors (SSRIs) in the treatment of moderate to severe obsessive-compulsive disorder: a systematic review and meta-analysis of randomized clinical trials.
    Eissazade N; Mosavari H; Eghdami S; Boroon M; Ashrafi F; Shalbafan M
    Sci Rep; 2023 Nov; 13(1):20837. PubMed ID: 38012263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A benzisothiazole derivative and antipsychotic agent, perospirone, for augmentation of selective serotonin reuptake inhibitors (SSRIs) in refractory obsessive-compulsive disorder (OCD): two patient case series.
    Matsunaga H; Matsui T; Ohya K; Okino K; Hayashida K; Maebayashi K; Kiriike N; Stein DJ
    Int J Psychiatry Clin Pract; 2006; 10(2):142-5. PubMed ID: 24940965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of lamotrigine augmentation in treatment-resistant obsessive compulsive disorder: a retrospective case review from South Asia.
    Hussain A; Dar MA; Wani RA; Shah MS; Jan MM; Malik YA; Chandel RK; Margoob MA
    Indian J Psychol Med; 2015; 37(2):154-8. PubMed ID: 25969599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Refining treatment approaches in obsessive-compulsive disorder.
    Fineberg N
    Int Clin Psychopharmacol; 1996 Dec; 11 Suppl 5():13-22. PubMed ID: 9032000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.
    Foster RH; Goa KL
    CNS Drugs; 1997 Aug; 8(2):163-88. PubMed ID: 23338224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repetitive transcranial magnetic stimulation (rTMS) augmentation of selective serotonin reuptake inhibitors (SSRIs) for SSRI-resistant obsessive-compulsive disorder (OCD): a meta-analysis of randomized controlled trials.
    Ma ZR; Shi LJ
    Int J Clin Exp Med; 2014; 7(12):4897-905. PubMed ID: 25663986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New treatment options for OCD.
    Fineberg NA
    Int J Psychiatry Clin Pract; 2007; 11 Suppl 2():24-30. PubMed ID: 24926869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of drug treatment in obsessive-compulsive disorder. A meta-analytic review.
    Piccinelli M; Pini S; Bellantuono C; Wilkinson G
    Br J Psychiatry; 1995 Apr; 166(4):424-43. PubMed ID: 7795913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lamotrigine as an augmentation agent in treatment-resistant obsessive-compulsive disorder: a case report.
    Uzun O
    J Psychopharmacol; 2010 Mar; 24(3):425-7. PubMed ID: 19010977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current trends in drug treatment of obsessive-compulsive disorder.
    Decloedt EH; Stein DJ
    Neuropsychiatr Dis Treat; 2010 May; 6():233-42. PubMed ID: 20520787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orgasm, Serotonin Reuptake Inhibition, and Plasma Oxytocin in Obsessive-Compulsive Disorder. Gleaning From a Distant Randomized Clinical Trial.
    Humble MB; Bejerot S
    Sex Med; 2016 Sep; 4(3):e145-55. PubMed ID: 27320409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological therapies for obsessive-compulsive disorder.
    Fallon BA; Mathew SJ
    J Psychiatr Pract; 2000 May; 6(3):113-28. PubMed ID: 15990479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The medical treatment of obsessive-compulsive disorder and anxiety.
    Bandelow B
    CNS Spectr; 2008 Sep; 13(9 Suppl 14):37-46. PubMed ID: 18849910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topiramate Augmentation in Resistant OCD: A Double-Blind Placebo-Controlled Clinical Trial.
    Mowla A; Khajeian AM; Sahraian A; Chohedri AH; Kashkoli F
    CNS Spectr; 2010 Nov; 15(11):613-7. PubMed ID: 24726048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aripiprazole augmentation in patients with resistant obsessive compulsive disorder: a pilot study.
    Delle Chiaie R; Scarciglia P; Pasquini M; Caredda M; Biondi M
    Clin Pract Epidemiol Ment Health; 2011; 7():107-11. PubMed ID: 21686322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antipsychotic augmentation in the treatment of obsessive-compulsive disorder.
    Thamby A; Jaisoorya TS
    Indian J Psychiatry; 2019 Jan; 61(Suppl 1):S51-S57. PubMed ID: 30745677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.